近期猴痘疫情的基因组与转录组分析
本研究对欧洲近期猴痘疫情的全基因组序列进行分析,并与历史猴痘、牛痘和天花病毒序列比较。结果显示近期疫情最可能源于西非分支,与1971至2017年序列同源性>99%,痘病毒科基因组高度保守,蛋白和核苷酸序列一致性分别为97.9%和97.8%,且三种痘病毒家族在人类细胞培养中诱导保守的免疫通路反应。
要点
- 近期猴痘疫情最可能起源于西非分支,与历史及近期病例序列同源性>99%。
- 痘病毒属基因组高度保守,蛋白和核苷酸序列一致性分别为97.9%和97.8%。
- 三种痘病毒家族在人类细胞培养中诱导保守的免疫通路反应。
核心结论
- 近期猴痘疫情最可能起源于西非分支,痘病毒科在基因组和转录组水平高度保守,为天花疫苗对其他痘病毒的有效性提供了分子基础。
研究设计与样本
- 对欧洲近期猴痘疫情的全基因组序列进行分析,并与按年份和地理来源注释的所有可用历史猴痘序列以及相关牛痘和天花病毒序列进行比较。
主要发现
- 近期疫情最可能起源于西非分支,与1971至2017年历史及近期病例序列同源性>99%。
- 近期疫情与其他猴痘/牛痘/天花病毒的全基因组序列分析显示高度保守,蛋白和核苷酸序列一致性分别为97.9%和97.8%。
- 人类转录反应显著相关,三种痘病毒家族在人类细胞培养中诱导保守的免疫通路反应。
关键数值与推荐
- 近期疫情与历史及近期病例序列同源性>99%。
- 痘病毒基因组蛋白序列一致性97.9%,核苷酸序列一致性97.8%。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Mpox (formerly named Monkeypox) virus is the etiological cause of a recent multi-country outbreak, with thousands of distinct cases detected outside the endemic areas of Africa as of December 2023. In this article, we analyze the sequences of full genomes of Mpox virus from Europe and compare them with all available Mpox sequences of historical relevance, annotated by year and geographic origin, as well as related Cowpox and Variola (smallpox) virus sequences. Our results show that the recent outbreak is most likely originating from the West African clade of Mpox, with >99 % sequence identity with sequences derived from historical and recent cases, dating from 1971 to 2017. We analyze specific mutations occurring in viral proteins between the current outbreak, previous Mpox and Cowpox sequences, and the historical Variola virus. Genome-wide sequence analysis of the recent outbreak and other Mpox/Cowpox/Variola viruses shows a very high conservation, with 97.9 % (protein-based) and 97.8 % (nucleotide-based) sequence identity. We identified significant correlation in human transcriptional responses as well, with a conserved immune pathway response induced in human cell cultures by the three families of Pox virus. The similarities identified between the major strains of Pox viruses, as well as within the Mpox clades, both at the genomic and transcriptomic levels, provide a molecular basis for the observed efficacy of Variola vaccines in other Poxviruses.
引用
- Giorgi FM, Pozzobon D, Di Meglio A, et al. Genomic and transcriptomic analysis of the recent Mpox outbreak. Vaccine. 2024. PMID: 38311533. doi:10.1016/j.vaccine.2023.12.086
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。